Analysts’ Viewpoint on Diagnostic Reagents Market Scenario
Health systems across the world seek to address unmet patient health needs for a range of acute and chronic diseases. Infectious diseases are a major cause of morbidity and mortality throughout the world. Discussions of laboratory innovations are often focused on automation and other advanced technologies that optimize and accelerate the work of scientists. Biomarkers and chemical reagents, however, play an equally important role in modern clinical laboratories. Manufacturers in the diagnostic reagents market are focusing on R&D activities and partnerships with academic institutes to maximize their gains. Additionally, development of new diagnostic tests is driving the demand for diagnostic reagents.
Diagnostics are the mainstay of detection, diagnosis, and assessment of any type of disease. More than 60% to 70% of medical decisions regarding disease treatment, management, and prevention are based on diagnostics. Diagnostics play a key role in preventive healthcare.
Diagnostics deliver information that can benefit patients by enabling the selection of the right treatment. They enable health professionals to choose appropriate preventive interventions and provide vital prognostic data that can optimize care pathways and management. In diagnostic testing, diagnostic reagents play a major role in medical labs, helping produce test results through diagnostic testing assays. Clinical diagnostic reagents are the most basic reagents. They use one or two reagent systems. These could be used for various tests including measuring serum albumin concentrations.
Diagnosis of infectious and chronic diseases is one of the leading applications of in vitro diagnostics reagents. Diagnostic reagents (both biological and chemical reagents) are an integral and vital part of any diagnostic test. Emergence and outbreak of various infectious diseases have created challenges and new opportunities for researchers to develop new diagnostic tools and tests for early diagnosis and prevention of diseases, and IVD reagents play a crucial role in it.
On March 11, 2020, the WHO declared the novel coronavirus (COVID-19) outbreak a global pandemic. Outbreak of new diseases such as COVID 19 and rise in demand for quick and better diagnosis of infectious diseases through in vitro diagnostics are likely to boost the demand for diagnostic reagents, especially IVD reagents, in the market.
Laboratory development test could become more common as we move toward new technologies and new approaches to clinical testing such as mass spectrometry. Researchers have characterized the effects of poor quality reagents in development of tests for diagnosis of diseases. Here, the importance of being able to trust the quality of reagents is amplified significantly.
Even within regulated markets, we cannot always be sure of ongoing quality; a quick search of the U.S. FDA Medical Device Recalls database shows multiple reagent recalls every year. This makes the pathway of small-scale diagnostic reagent manufacturers quite different to maintain the strict regulatory quality for reagents in the diagnostic reagents facility due to requirement of large capital investment to maintain the stock. Hence, they are unable to cater to the big diagnostic players who always look for good quality reagents.
In terms of end-user, the global diagnostic reagents market has been divided into hospitals & diagnostic laboratories, academic & research institutes, and others. Rise in number of hospitals with diagnostic labs in developing countries, increase in patient preference to visit hospitals for reimbursement facilities, availability of advanced diagnostic services, and ability to perform various types of tests are expected to drive the hospitals & diagnostic laboratories segment during the forecast period. As of February 2019, there were a total of 33,000 hospitals in China, an increase of 1,866 compared to the same period in 2018.
North America accounted for a prominent share of the global diagnostic reagents market in 2021. The trend is projected to continue during the forecast period due to the rise in healthcare care spending for prevention of diseases, adoption of quick innovative tests, and high degree of awareness about routine tests to maintain healthy life in the region.
The diagnostic reagents market in Asia Pacific is anticipated to grow at a high CAGR from 2022 to 2031. This can be ascribed to the increase in popularity of molecular test over traditional tests such as microbiology test, surge in incidence of lifestyle-related & chronic illnesses, and technical developments in countries such as India, Indonesia, Thailand, and South Korea.
The global diagnostic reagents market is fragmented, with the presence of large number of players. Key players operating in the global diagnostic reagents market include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG, F. Hoffmann-La Roche AG, DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., and Agilent Technologies, Inc. Leading diagnostic reagents manufacturers are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers.
Each of these players has been profiled in the diagnostics reagents market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 45.7 Bn |
|
Market Forecast Value in 2031 |
More than US$ 85.8 Bn |
|
Growth Rate (CAGR) |
6.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, regulatory scenario, list of major reagents, and risk entry analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global diagnostic reagents market was valued at US$ 45.7 Bn in 2021
The global diagnostic reagents market is projected to reach more than US$ 85.8 Bn by 2031
The global diagnostic reagents market is anticipated to grow at a CAGR of 6.5% from 2022 to 2031
Rise in research & development activities, increase in demand for point-of-care testing, and surge in number of diagnostic labs are driving the global diagnostic reagents market
The immunoassays segment held more than 27% share of the global diagnostic reagents market in 2021
North America is expected to account for major share of the global diagnostic reagents market during the forecast period
Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG, F. Hoffmann-La Roche AG, DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc. and Agilent Technologies, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Reagents Market
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Diagnostic Reagents Market Analysis and Forecast, 2017–2031
4.3.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. List of Mostly Used Diagnostic Reagents
5.2. Key Industry Development
5.3. COVID-19 Impact Analysis
6. Global Diagnostic Reagents Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Chromatography Reagents
6.3.2. Molecular Diagnostic Reagents
6.3.3. Immunoassay Reagents
6.3.4. Clinical Chemistry Reagents
6.3.5. Flow Cytometry Reagents
6.3.6. Cell & Tissue Culture Reagents
6.3.7. Hematology & Hemostasis Reagents
6.3.8. Microbiology Reagents
6.3.9. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Diagnostic Reagents Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals & Diagnostics Laboratories
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Diagnostic Reagents Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region/Country
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Diagnostic Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Chromatography Reagents
9.2.2. Molecular Diagnostic Reagents
9.2.3. Immunoassay Reagents
9.2.4. Clinical Chemistry Reagents
9.2.5. Flow Cytometry Reagents
9.2.6. Cell & Tissue Culture Reagents
9.2.7. Hematology & Hemostasis Reagents
9.2.8. Microbiology Reagents
9.2.9. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Diagnostics Laboratories
9.3.2. Academic & Research Institutes
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Diagnostic Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Chromatography Reagents
10.2.2. Molecular Diagnostic Reagents
10.2.3. Immunoassay Reagents
10.2.4. Clinical Chemistry Reagents
10.2.5. Flow Cytometry Reagents
10.2.6. Cell & Tissue Culture Reagents
10.2.7. Hematology & Hemostasis Reagents
10.2.8. Microbiology Reagents
10.2.9. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals & Diagnostics Laboratories
10.3.2. Academic & Research Institutes
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Diagnostic Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Chromatography Reagents
11.2.2. Molecular Diagnostic Reagents
11.2.3. Immunoassay Reagents
11.2.4. Clinical Chemistry Reagents
11.2.5. Flow Cytometry Reagents
11.2.6. Cell & Tissue Culture Reagents
11.2.7. Hematology & Hemostasis Reagents
11.2.8. Microbiology Reagents
11.2.9. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals & Diagnostics Laboratories
11.3.2. Academic & Research Institutes
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Diagnostic Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Chromatography Reagents
12.2.2. Molecular Diagnostic Reagents
12.2.3. Immunoassay Reagents
12.2.4. Clinical Chemistry Reagents
12.2.5. Flow Cytometry Reagents
12.2.6. Cell & Tissue Culture Reagents
12.2.7. Hematology & Hemostasis Reagents
12.2.8. Microbiology Reagents
12.2.9. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals & Diagnostics Laboratories
12.3.2. Academic & Research Institutes
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Diagnostic Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Chromatography Reagents
13.2.2. Molecular Diagnostic Reagents
13.2.3. Immunoassay Reagents
13.2.4. Clinical Chemistry Reagents
13.2.5. Flow Cytometry Reagents
13.2.6. Cell & Tissue Culture Reagents
13.2.7. Hematology & Hemostasis Reagents
13.2.8. Microbiology Reagents
13.2.9. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals & Diagnostics Laboratories
13.3.2. Academic & Research Institutes
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Global & India IVD Reagents Market Analysis and Forecast, by Chemical Type
14.1. Market Value Forecast, by Chemical Type, 2017–2031
14.1.1. Bio-chemical
14.1.2. Immunochemical
14.2. Value Chain Analysis
14.3. Market Value Forecast, India & Global
14.4. Key Trends
14.5. Winning Imperative and Key Entry Barriers
14.6. Regulatory Requirements
14.7. List of Global and Indian Players
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Market Share (2021)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. BD
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. F. Hoffmann-La Roche AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. DiaSorin S.p.A
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Sysmex Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. bioMerieux SA
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Ortho Clinical Diagnostics
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Thermo Fisher Scientific, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Agilent Technologies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Diagnostic Reagents Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Diagnostic Reagents Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 07: Europe Diagnostic Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 09: Europe Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 10: Asia Pacific Diagnostic Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 13: China Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 14: China Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 15: India Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 16: India Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 17: Latin America Diagnostic Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 20: Middle East & Africa Diagnostic Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Diagnostic Reagents Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 22: Middle East & Africa Diagnostic Reagents Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 23: Global Chemical Reagents Market Value (US$ Mn) Forecast, by Chemical Type, 2017‒2031
Table 24: India Chemical Reagents Market Value (US$ Mn) Forecast, by Chemical Type, 2017‒2031
List of Figures
Figure 01: Global Diagnostic Reagents Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Diagnostic Reagents Market Value Share, by Product, 2021
Figure 03: Global Diagnostic Reagents Market Value Share, by End-user, 2021
Figure 04: Global Diagnostic Reagents Market Value Share, by Region, 2021
Figure 05: Global Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 06: Global Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 08: Global Diagnostic Reagents Market Value (US$ Mn), by Molecular Diagnostic Reagents, 2017–2031
Figure 09: Global Diagnostic Reagents Market Value (US$ Mn), by Chromatography Reagents, 2017–2031
Figure 10: Global Diagnostic Reagents Market Value (US$ Mn), by Immunoassay Reagents, 2017–2031
Figure 11: Global Diagnostic Reagents Market Value (US$ Mn), by Clinical Chemistry Reagents, 2017–2031
Figure 12: Global Diagnostic Reagents Market Value (US$ Mn), by Flow Cytometry Reagents, 2017–2031
Figure 13: Global Diagnostic Reagents Market Value (US$ Mn), by Cell & Tissue Culture Reagents, 2017–2031
Figure 14: Global Diagnostic Reagents Market Value (US$ Mn), by Hematology & Hematostasis Reagents, 2017–2031
Figure 15: Global Diagnostic Reagents Market Value (US$ Mn), by Microbiology Reagents, 2017–2031
Figure 16: Global Diagnostic Reagents Market Value (US$ Mn), by Others, 2017–2031
Figure 17: Global Diagnostic Reagents Market, by End-user, 2021 and 2031
Figure 18: Global Diagnostic Reagents Market, by End-user, 2022-2031
Figure 19: Global Diagnostic Reagents Market Value (US$ Mn), by Hospital & Diagnostic Laboratories, 2017–2031
Figure 20: Global Diagnostic Reagents Market Value (US$ Mn), by Academic & Research Institutes, 2017–2031
Figure 21: Global Diagnostic Reagents Market Value (US$ Mn), by Others, 2017–2031
Figure 22: Global Diagnostic Reagents Market Value Share Analysis, by Region, 2021 and 2031
Figure 23: Global Diagnostic Reagents Market Attractiveness Analysis, by Region, 2022-2031
Figure 24: North America Diagnostic Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 25: North America Diagnostic Reagents Market Value Share Analysis, by Country, 2021 and 2031
Figure 26: North America Diagnostic Reagents Market Attractiveness Analysis, by Country, 2022–2031
Figure 27: North America Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 28: North America Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 29: North America Diagnostic Reagents Market, by End-user, 2021 and 2031
Figure 30: North America Diagnostic Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 31: Europe Diagnostic Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 32: Europe Diagnostic Reagents Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 33: Europe Diagnostic Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 34: Europe Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 35: Europe Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 36: Europe Diagnostic Reagents Market, by End-user, 2021 and 2031
Figure 37: Europe Diagnostic Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 38: Asia Pacific Diagnostic Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 39: Asia Pacific Diagnostic Reagents Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 40: Asia Pacific Diagnostic Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 41: Asia Pacific Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 42: Asia Pacific Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 43: Asia Pacific Diagnostic Reagents Value Share Analysis, by End-user, 2021 and 2031
Figure 44: Asia Pacific Diagnostic Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 45: China Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 46: China Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 47: China Diagnostic Reagents Market Value Share Analysis, by End-user, 2021 and 2031
Figure 48: China Diagnostic Reagents Market Attractiveness Analysis, by End-user, 2022 - 2031
Figure 49: India Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 50: India Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 51: India Diagnostic Reagents Market Value Share Analysis, by End-user, 2021 and 2031
Figure 52: India Diagnostic Reagents Market Attractive Analysis, by End-user, 2022-2031
Figure 53: Latin America Diagnostic Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 54: Latin America Diagnostic Reagents Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 55: Latin America Diagnostic Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 56: Latin America Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 57: Latin America Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 58: Latin America Diagnostic Reagents Market, by End-user, 2021 and 2031
Figure 59: Latin America Diagnostic Reagents Market Attractiveness Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Diagnostic Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 61: Middle East & Africa Diagnostic Reagents Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 62: Middle East & Africa Diagnostic Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 63: Middle East & Africa Diagnostic Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 64: Middle East & Africa Diagnostic Reagents Market Attractiveness Analysis, by Product, 2022–2031
Figure 65: Middle East & Africa Diagnostic Reagents Market, by End-user, 2021 and 2031
Figure 66: Middle East & Africa Diagnostic Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 67: Global Chemical Reagents Market Value (US$ Mn) Forecast, 2017–2031
Figure 68: India Chemical Reagents Market Value (US$ Mn) Forecast, 2017–2031
Figure 69: Global Chemical Reagents Market Share Value Analysis- by Chemical Type, 2021
Figure 70: India Chemical Reagents Market Share Value Analysis- by Chemical Type, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Diagnostic Reagents Market
